Celldex Therapeutics, Inc. (NASDAQ:CLDX) today announced that the Company has initiated a Phase 2 study of barzolvolimab in atopic dermatitis (AD) and that the study is actively enrolling patients. AD ...

This study identifies key differences in nasal fungi composition in asthma and allergy patients, offering insights into their ...

Indiana University School of Medicine researchers have uncovered compelling evidence that children with primary ciliary ...

A study links patient-reported asthma symptoms to specific lung function and inflammation markers, revealing potential for personalised treatments. Learn how distinct symptoms like cough and wheezing ...

US FDA accepts GSK’s submission for the use of Nucala to treat patients with chronic obstructive pulmonary disease: London, UK Wednesday, December 11, 2024, 10:00 Hrs [IST] GSK ...

Metformin, lifestyle changes, or their combination did not significantly reduce AFib burden compared to standard care in the TRIM-AF trial. Weight loss was observed in intervention groups, but ...

1 Division of Pulmonary and Critical Care, Department of Internal Medicine, Tannourine Governmental Hospital, Batroun, Lebanon. 2 Division of Pulmonary and Critical Care, Department of Internal ...

For the first time in half a century, scientists have hit on a new treatment for asthma attacks. Clinical trial results have ...

Although capnography is not able to tell everything we need to know about all our patients, for many patients, capnography is ...

This article will review the pathophysiology of asthma, the physiologic changes in pregnancy, the determinants of fetal oxygenation, and options for appropriate and effective medical management ...

The first new treatment for asthma attacks in 50 years has been hailed as a "game-changer" by doctors and patients. A clinical trial of the drug benralizumab showed it was far more effective than ...